Medical News

RSS

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, today reported positive clinical data from a Phase 2 trial evaluating JX-594 for liver cancer which was conducted in South Korea.

21 Apr 2011

Rate of antiretroviral virological failure higher among children living with HIV/AIDS than adults, study finds

One in eight children living with HIV/AIDS "experiences triple-class virological failure - meaning the virus becomes resistant to multiple drugs - within five years of starting antiretroviral treatment," according to a study published Wednesday in the Lancet, HealthDay News/MSN reports. The "failure rate is higher than in adults and highlights the challenge of maintaining viral load suppression in young patients who begin antiretroviral therapy so early in life, the researchers said," according to the news service (Preidt, 4/19).

21 Apr 2011

Hanmi granted exclusive rights to Kinex KX01 Src kinase/pretubulin dual mechanism inhibitor for oncology indications

Kinex Pharmaceuticals, LLC and Hanmi Pharmaceutical Co., Ltd. announced today the execution of a license agreement granting Hanmi Pharmaceuticals exclusive rights to their lead compound, KX01, for all oncology indications in selected Asian Territories.

21 Apr 2011

Veterans with mental illness show increased rates of substance use disorders

A new study published in The American Journal on Addictions reveals that Veterans who suffer from mental health disorders also have high rates of substance use disorders.

21 Apr 2011

Penn researchers explore the role of telomere caps in human aging

Researchers at the University of Pennsylvania School of Medicine are delving into the details of the complex structure at the ends of chromosomes.

21 Apr 2011

LabCorp first quarter revenues increase 14.6% to $1,368.4 million

Laboratory Corporation of America® Holdings today announced results for the quarter ended March 31, 2011. These results include the operations of Genzyme Genetics, which the Company acquired in the fourth quarter of 2010.

21 Apr 2011

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

Biomagnetics Diagnostics Corp., (PINK SHEETS: BMGP) a developer of revolutionary diagnostic systems and related technology for detecting HIV, hepatitis, tuberculosis, cholera and malaria, and other innovative technologies, today announced it has now completed a series of payments to Los Alamos National Laboratory (LANL) pursuant to the cooperative research and development agreement (CRADA) executed in 2010 between the two organizations.

21 Apr 2011

ICA selected by Central Illinois HIE as vendor of choice

Informatics Corporation of America announced today that it has been selected by the Central Illinois Health Information Exchange (CIHIE), www.qualityquest.org, as its health information exchange vendor of choice and has begun contract negotiations to furnish the technology and infrastructure for a regional HIE that will serve 20 counties in the Peoria, Bloomington, Champaign, and Decatur areas of Illinois.

21 Apr 2011

Roundup: Abortion opponents weigh strategy; Supreme Court reinstates case involving deaths at Va. hospitals

Republican legislatures across the country are passing tough new anti-abortion laws — and while abortion rights advocates believe the new laws are unconstitutional, they're not rushing to court to stop them. The reason: There's a decent chance they'd lose (Kliff, 4/20).

21 Apr 2011

Covidien second quarter net sales up 10% to $2.80 billion

Covidien plc today reported results for the second quarter of fiscal 2011 (January - March 2011). Net sales of $2.80 billion increased 10% from the $2.55 billion reported in the second quarter a year ago. Foreign exchange rate movement added approximately two percentage points to the quarterly sales growth rate.

21 Apr 2011

Sedentary lifestyle in childhood narrows vessels in the retina and increases risk of cardiovascular disease

Six-year-olds who spent the most time watching television, using a computer or playing video games had narrower arteries in the back of their eyes — a marker of future cardiovascular risk, in a first-of-its-kind study reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.

21 Apr 2011

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2011 results.

21 Apr 2011

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

The Stanford University School of Medicine and SanBio Inc. today announced the initiation of a Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic cell therapy product, SB623, on patients suffering from stable deficits resulting from previous stroke injuries.

21 Apr 2011

ICON first quarter net revenue increases 4.6% to $229 million

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2011.

21 Apr 2011

Nursing home industry worried about health law mandates; Cuts to Medicare, Medicaid

During a roundtable meeting with reporters, Mark Parkinson, president of the American Health Care Association, detailed the concerns of nursing homes.

21 Apr 2011

KellBenx secures $2.5 million from initial funding round

KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors – three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.

21 Apr 2011

Four new Research Units established by the German Research Foundation

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) establishes four new Research Units. This decision has just been made by the Senate of the DFG at its meeting in Bonn in April. In Research Units, outstanding researchers work together on a current research topic, often at different locations and across disciplines.

21 Apr 2011

Antenatal infection and ventilation with BPD associated with excessive accumulation of dendritic cells in lungs

Rates of premature births have increased in recent years, affecting more than 12% of all births and making strategies for managing the associated perinatal complications an important public goal. Preterm infants are particularly at risk for bronchopulmonary dysplasia (BPD), a chronic lung disease. BPD has multiple causes, and uncovering critical interactions within the immune system can lead to new approaches for treatment.

21 Apr 2011

Normal routine use of topical corticosteroids for eczema in children does not 'thin the skin'

A new study published in the journal Pediatric Dermatology reveals that routine, long-term use of topical corticosteroids (TCS) for treating children with eczema does not cause any significant, negative side effects.

21 Apr 2011

Humans have three different gut types, finds study

In the future, when you walk into a doctor's surgery or hospital, you could be asked not just about your allergies and blood group, but also about your gut type. Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, and collaborators in the international MetaHIT consortium, have found that humans have 3 different gut types.

21 Apr 2011

Medical News

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Rate of antiretroviral virological failure higher among children living with HIV/AIDS than adults, study finds

Hanmi granted exclusive rights to Kinex KX01 Src kinase/pretubulin dual mechanism inhibitor for oncology indications

Veterans with mental illness show increased rates of substance use disorders

Penn researchers explore the role of telomere caps in human aging

LabCorp first quarter revenues increase 14.6% to $1,368.4 million

Biomagnetics signs agreement with LANL to develop validated TB biomarker assay

ICA selected by Central Illinois HIE as vendor of choice

Roundup: Abortion opponents weigh strategy; Supreme Court reinstates case involving deaths at Va. hospitals

Covidien second quarter net sales up 10% to $2.80 billion

Sedentary lifestyle in childhood narrows vessels in the retina and increases risk of cardiovascular disease

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Stanford and SanBio initiate SB623 Phase 1/2a clinical trial for stroke disability

ICON first quarter net revenue increases 4.6% to $229 million

Nursing home industry worried about health law mandates; Cuts to Medicare, Medicaid

KellBenx secures $2.5 million from initial funding round

Four new Research Units established by the German Research Foundation

Antenatal infection and ventilation with BPD associated with excessive accumulation of dendritic cells in lungs

Normal routine use of topical corticosteroids for eczema in children does not 'thin the skin'

Humans have three different gut types, finds study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News